AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
BAX vs VRTX Fundamental Comparison
| Metric | BAX | VRTX |
|---|---|---|
| Revenue | $2.7B | $3.0B |
| Net Income | $-15.0M | $1.0B |
| Net Margin | -0.6% | 34.5% |
| ROE | -0.2% | 5.3% |
| ROA | -0.1% | 3.9% |
| Current Ratio | 1.85x | 3.02x |
| Debt/Equity | 1.56x | 0.01x |
| EPS | $-0.03 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BAX vs VRTX: Frequently Asked Questions
Is BAX or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. BAX is graded C (84% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does BAX compare to VRTX fundamentally?
BAXTER INTERNATIONAL INC has ROE of -0.2% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are -0.6% vs 34.5% respectively.
Which stock pays higher dividends, BAX or VRTX?
BAX has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BAX or VRTX for long term?
For long-term investing, consider that BAX has a C grade with 84% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BAX vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BAX vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.